SCHEMBL1778262

SCHEMBL1778262

Cc1cc(Br)ccc1OCCCCl

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.52
RAB9A P51151 1/20 0.52
KMT2A Q03164 4/20 0.51
ALDH1A1 P00352 5/20 0.50
MEN1 O00255 3/20 0.50
LMNA P02545 2/20 0.49
TDP1 Q9NUW8 1/20 0.48
PKM P14618 1/20 0.46
HPGD P15428 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
POLB P06746 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.44
TP53 P04637 1/20 0.44
ALOX15 P16050 1/20 0.44
HTT P42858 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12121221 0.85 KDM4E (0.52) KDM4ERAB9AKMT2AALDH1A1MEN1
SCHEMBL525666 0.85 ALDH1A1 (0.48) KDM4ERAB9AKMT2AALDH1A1MEN1
SCHEMBL4816249 0.83 HPGD (0.57) KDM4ERAB9AKMT2AALDH1A1MEN1
SCHEMBL30394686 0.82 HPGD (0.42) KDM4ERAB9AKMT2AALDH1A1MEN1
SCHEMBL19897876 0.82 HPGD (0.42) KDM4ERAB9AKMT2AALDH1A1MEN1
SCHEMBL27717344 0.81 KMT2A (0.50) KDM4ERAB9AKMT2AALDH1A1MEN1
SCHEMBL3182217 0.81 KDM4E (0.59) KDM4ERAB9AKMT2AALDH1A1MEN1
SCHEMBL4573266 0.81 KDM4E (0.58) KDM4ERAB9AKMT2AALDH1A1MEN1
SCHEMBL13642366 0.81 KMT2A (0.50) KDM4ERAB9AKMT2AALDH1A1MEN1
SCHEMBL7228685 0.81 TDP1 (0.54) KDM4ERAB9AKMT2AALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7943605-B2 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses UCB PHARMA S.A. (BE) 2011-05-17 US disclosed
US-20090023708-A1 Compounds Comprising a Lactam or a Lactam Derivative Moiety, Processes for Making Them, and Their Uses UCB PHARMA, S.A. (BE) 2009-01-22 US disclosed
CN-101296902-A Compounds comprising lactam or lactam derivative moieties, processes for preparing them and their use UCB PHARMA SA (BE) 2008-10-29 CN disclosed
EP-1943217-A1 COMPOUNDS COMPRISING A LACTAM OR A LACTAM DERIVATIVE MOIETY, PROCESSES FOR MAKING THEM, AND THEIR USES UCB Pharma, S.A. (BE) 2008-07-16 EP disclosed
WO-2007048595-A1 COMPOUNDS COMPRISING A LACTAM OR A LACTAM DERIVATIVE MOIETY, PROCESSES FOR MAKING THEM, AND THEIR USES UCB PHARMA, S.A. (BE) 2007-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090023708-A1 Compounds Comprising a Lactam or a Lactam Derivative Moiety, Processes for Making Them, and Their Uses COASY, FURIN, PEPD KDM4E 2604/4885RAB9A 782/4885KMT2A 3477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.